North America Insulin Delivery Market Outlook to 2022

North America Insulin Delivery Market Outlook to 2022


  • Products Id :- GDMECR0558DB
  • |
  • Pages: 211
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

North America Insulin Delivery Market Outlook to 2022

Summary

GlobalData's new report, "North America Insulin Delivery Market Outlook to 2022", provides key market data on the North America Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Insulin Delivery market segments-Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.

2015 company shares and distribution shares data for each of the market segements.

Global corporate-level profiles of key companies operating within the North America Insulin Delivery market.

Key players covered include Medtronic plc, Becton Dickinson and Co, Eli Lilly and Company, Insulet Corp, Novo Nordisk A/S and Others.

Reasons to Buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 8

2 Introduction 10

2.1 What Is This Report About? 10

2.2 Insulin Delivery Market Segmentation 10

2.3 Definitions of Markets Covered in the Report 11

3 Insulin Delivery Market, North America 13

3.1 Insulin Delivery Market, North America, Revenue ($m), 2008-2022 13

3.2 Insulin Delivery Market, North America, Category Comparison by Revenue ($m), 2008-2022 14

3.3 Insulin Delivery Market, North America, Revenue ($m), 2008-2015 15

3.4 Insulin Delivery Market, North America, Revenue ($m), 2015-2022 17

3.5 Insulin Delivery Market, North America, Volume (Units), 2008-2022 19

3.6 Insulin Delivery Market, North America, Volume (Units), 2008-2015 21

3.7 Insulin Delivery Market, North America, Volume (Units), 2015-2022 23

3.8 Insulin Delivery Market, North America, Company Share by Revenue ($m), 2015 25

4 Insulin Delivery Market, Canada 27

4.1 Insulin Delivery Market, Canada, Revenue ($m), 2008-2015 27

4.2 Insulin Delivery Market, Canada, Revenue ($m), 2015-2022 29

4.2.1 Insulin Pens Market, Canada, Revenue ($m), by Segment, 2008-2015 31

4.2.2 Insulin Pumps Market, Canada, Revenue ($m), by Segment, 2008-2015 33

4.2.3 Insulin Pens Market, Canada, Revenue ($m), by Segment, 2015-2022 35

4.2.4 Insulin Pumps Market, Canada, Revenue ($m), by Segment, 2015-2022 37

4.3 Insulin Delivery Market, Canada, Volume (Units), 2008-2015 39

4.4 Insulin Delivery Market, Canada, Volume (Units), 2015-2022 41

4.4.1 Insulin Pens Market, Canada, Volume (Units), by Segment, 2008-2015 43

4.4.2 Insulin Pumps Market, Canada, Volume (Units), by Segment, 2008-2015 45

4.4.3 Insulin Pens Market, Canada, Volume (Units), by Segment, 2015-2022 47

4.4.4 Insulin Pumps Market, Canada, Volume (Units), by Segment, 2015-2022 49

4.5 Insulin Delivery Market, Canada, Average Price ($), 2008-2022 51

4.6 Insulin Delivery Market, Canada, Distribution Share by Revenue ($m), 2014-2015 53

4.7 Insulin Delivery Market, Canada, Company Share by Revenue ($m), 2015 54

5 Insulin Delivery Market, Mexico 56

5.1 Insulin Delivery Market, Mexico, Revenue ($m), 2008-2015 56

5.2 Insulin Delivery Market, Mexico, Revenue ($m), 2015-2022 58

5.2.1 Insulin Pens Market, Mexico, Revenue ($m), by Segment, 2008-2015 60

5.2.2 Insulin Pumps Market, Mexico, Revenue ($m), by Segment, 2008-2015 62

5.2.3 Insulin Pens Market, Mexico, Revenue ($m), by Segment, 2015-2022 63

5.2.4 Insulin Pumps Market, Mexico, Revenue ($m), by Segment, 2015-2022 65

5.3 Insulin Delivery Market, Mexico, Volume (Units), 2008-2015 66

5.4 Insulin Delivery Market, Mexico, Volume (Units), 2015-2022 68

5.4.1 Insulin Pens Market, Mexico, Volume (Units), by Segment, 2008-2015 70

5.4.2 Insulin Pumps Market, Mexico, Volume (Units), by Segment, 2008-2015 72

5.4.3 Insulin Pens Market, Mexico, Volume (Units), by Segment, 2015-2022 73

5.4.4 Insulin Pumps Market, Mexico, Volume (Units), by Segment, 2015-2022 75

5.5 Insulin Delivery Market, Mexico, Average Price ($), 2008-2022 76

5.6 Insulin Delivery Market, Mexico, Distribution Share by Revenue ($m), 2014-2015 78

5.7 Insulin Delivery Market, Mexico, Company Share by Revenue ($m), 2015 79

6 Insulin Delivery Market, United States 81

6.1 Insulin Delivery Market, United States, Revenue ($m), 2008-2015 81

6.2 Insulin Delivery Market, United States, Revenue ($m), 2015-2022 83

6.2.1 Insulin Pens Market, United States, Revenue ($m), by Segment, 2008-2015 85

6.2.2 Insulin Pumps Market, United States, Revenue ($m), by Segment, 2008-2015 87

6.2.3 Insulin Pens Market, United States, Revenue ($m), by Segment, 2015-2022 89

6.2.4 Insulin Pumps Market, United States, Revenue ($m), by Segment, 2015-2022 91

6.3 Insulin Delivery Market, United States, Volume (Units), 2008-2015 93

6.4 Insulin Delivery Market, United States, Volume (Units), 2015-2022 95

6.4.1 Insulin Pens Market, United States, Volume (Units), by Segment, 2008-2015 97

6.4.2 Insulin Pumps Market, United States, Volume (Units), by Segment, 2008-2015 99

6.4.3 Insulin Pens Market, United States, Volume (Units), by Segment, 2015-2022 101

6.4.4 Insulin Pumps Market, United States, Volume (Units), by Segment, 2015-2022 103

6.5 Insulin Delivery Market, United States, Average Price ($), 2008-2022 105

6.6 Insulin Delivery Market, United States, Distribution Share by Revenue ($m), 2014-2015 107

6.7 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2015 108

7 Overview of Key Companies in North America Insulin Delivery Market 110

7.1 Eli Lilly and Company 110

7.1.1 Company Overview 110

7.2 Becton Dickinson and Co 110

7.2.1 Company Overview 110

7.3 Medtronic plc 110

7.3.1 Company Overview 110

7.4 Novo Nordisk A/S 111

7.4.1 Company Overview 111

7.5 Sanofi 111

7.5.1 Company Overview 111

7.6 Insulet Corp 111

7.6.1 Company Overview 111

7.7 F. Hoffmann-La Roche Ltd 111

7.7.1 Company Overview 111

7.8 Tandem Diabetes Care, Inc. 112

7.8.1 Company Overview 112

7.9 B. Braun Melsungen AG 112

7.9.1 Company Overview 112

8 Insulin Delivery Market Pipeline Products 113

9 Recent Developments 114

9.1 Corporate Communications 114

9.1.1 Nov 30, 2016: Valeritas Elects Joe Mandato, Ph.D., Experienced Medical Device Executive and Investor, to Board of Directors 114

9.1.2 Oct 31, 2016: Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer 114

9.1.3 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan 115

9.1.4 Sep 22, 2016: Industry Veteran Katherine D. Crothall, PhD to Join Valeritas Board of Directors 115

9.1.5 Sep 14, 2016: Levi Garraway, M.D., Ph.D., to become Senior Vice President of Global Oncology at Lilly, Succeeding Richard Gaynor, M.D., Who is Retiring after a Distinguished Career 116

9.1.6 Sep 06, 2016: Insulet Announces Executive Appointments 117

9.1.7 Aug 31, 2016: Jamere Jackson Elected To Lilly Board Of Directors 117

9.1.8 Aug 16, 2016: Valeritas Appoints Erick J. Lucera as Chief Financial Officer 118

9.1.9 Aug 10, 2016: Lilly announces Joshua Smiley, Anat Ashkenazi appointed to new roles, Thomas Grein retires 119

9.1.10 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 119

9.1.11 Jul 27, 2016: John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Successor 120

9.1.12 Jul 13, 2016: Valeritas Appoints Brian K. Roberts to its Board of Directors 121

9.1.13 Jun 27, 2016: ConvaTec Provides Business Updates 122

9.1.14 Jun 23, 2016: Valeritas Appoints David Lewis as Vice President of Marketing 122

9.1.15 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 122

9.1.16 Jun 13, 2016: Aarti Shah named chief information officer 123

9.1.17 Jun 02, 2016: Nektar Therapeutics Announces Executive Management Promotions 124

9.1.18 Apr 25, 2016: Peter J. Devlin Joins Valeritas Board of Directors as Independent Director 125

9.1.19 Apr 19, 2016: Rodney D. Altman, MD Joins Valeritas Board of Directors 125

9.1.20 Apr 08, 2016: Dr. Henry Anhalt to Step Down From Tandem Diabetes Care Board of Directors to Ensure No Risk of Potential Conflict of Interest 126

9.1.21 Mar 23, 2016: Renowned scientist will lead rare mission to address the epidemic of heart failure 126

9.1.22 Mar 16, 2016: Insulet Names Aiman Abdel-Malek, Ph.D. Senior Vice President of Advanced Technology and Engineering 127

9.1.23 Mar 14, 2016: Tandem Diabetes Care Announces Appointment of Dr. Henry Anhalt as Board Member 127

9.1.24 Mar 14, 2016: MannKind Announces Appointment of Michael Castagna as Chief Commercial Officer 128

9.1.25 Mar 02, 2016: Insulet Announces Organizational Enhancements 128

9.1.26 Feb 25, 2016: Valeritas Announces Leadership and Board of Directors Changes 129

9.1.27 Feb 09, 2016: Insulet Appoints David A. Lemoine to Board of Directors 130

9.1.28 Feb 02, 2016: Tandem Diabetes Care Expands Commercial Leadership 131

9.1.29 Jan 26, 2016: Antares Pharma Announces CEO Transition 131

9.1.30 Jan 19, 2016: Johnson & Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace 132

9.1.31 Dec 23, 2015: MannKind Announces Appointment of Duane DeSisto as Chief Executive Officer 132

9.2 Financial Announcements 133

9.2.1 Nov 14, 2016: Retractable Technologies Reports Results as of September 30, 2016 133

9.2.2 Nov 10, 2016: Valeritas Reports Third Quarter 2016 Financial Results 134

9.2.3 Nov 09, 2016: Antares Pharma Reports Third Quarter 2016 Financial and Operating Results 135

9.2.4 Nov 09, 2016: Aradigm Announces Third Quarter 2016 Financial Results 137

9.2.5 Nov 09, 2016: MannKind Reports 2016 Third Quarter Financial Results 138

9.2.6 Nov 03, 2016: Nektar Therapeutics Reports Financial Results for the Third Quarter of 2016 140

9.2.7 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 142

9.2.8 Nov 03, 2016: Insulet Reports Third Quarter 2016 Financial Results 143

9.2.9 Nov 01, 2016: Tandem Diabetes Care Reports Third Quarter 2016 Financial Results 144

9.2.10 Oct 25, 2016: Lilly Reports Third-Quarter 2016 Results 146

9.2.11 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 151

9.2.12 Aug 16, 2016: Retractable Technologies Reports Results as of June 30, 2016 152

9.2.13 Aug 10, 2016: Aradigm Announces Second Quarter 2016 Financial Results 154

9.2.14 Aug 10, 2016: Valeritas Reports Second Quarter 2016 Financial Results 155

9.2.15 Aug 09, 2016: Antares Pharma Reports Second Quarter 2016 Operating and Financial Results 156

9.2.16 Aug 08, 2016: MannKind Reports 2016 Second Quarter Financial Results 158

9.2.17 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 159

9.2.18 Aug 03, 2016: Nektar Therapeutics Reports Financial Results for the Second Quarter of 2016 160

9.2.19 Aug 03, 2016: Insulet Reports Second Quarter 2016 Financial Results 162

9.2.20 Jul 28, 2016: Integer Holdings Reports 2016 Second Quarter Results 163

9.2.21 Jul 26, 2016: Lilly Reports Second-Quarter 2016 Results, Provides Financial Expectations Through The Remainder Of The Decade 166

9.2.22 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 170

9.2.23 May 17, 2016: Retractable Technologies Reports Results for the First Quarter of 2016 172

9.2.24 May 10, 2016: Aradigm Announces First Quarter 2016 Financial Results 173

9.2.25 May 09, 2016: Antares Pharma Reports First Quarter 2016 Operating and Financial Results 174

9.2.26 May 09, 2016: MannKind Reports 2016 First Quarter Financial Results 176

9.2.27 May 03, 2016: Insulet Reaffirms Second Quarter and Full Year 2016 Guidance 176

9.2.28 Apr 28, 2016: Greatbatch Reports 2016 First Quarter Results 177

9.2.29 Apr 28, 2016: Tandem Diabetes Care Reports First Quarter 2016 Financial Results and Updates 2016 Guidance 179

9.2.30 Apr 28, 2016: Insulet Reports First Quarter 2016 Financial Results 180

9.2.31 Apr 19, 2016: Johnson & Johnson Reports 2016 First-Quarter Results 181

9.2.32 Apr 01, 2016: Retractable Technologies Reports Results for the Year 2015 183

9.2.33 Mar 08, 2016: Antares Pharma Reports Fourth Quarter and Full Year 2015 Operating and Financial Results 184

9.2.34 Feb 29, 2016: Greatbatch Reports 2015 Fourth Quarter and Full Year Results 185

9.2.35 Feb 25, 2016: Insulet Reports Fourth Quarter and Full Year 2015 Financial Results 189

9.2.36 Feb 24, 2016: Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial Results 190

9.2.37 Jan 26, 2016: Johnson & Johnson Reports 2015 Fourth-Quarter Results 191

9.2.38 Jan 11, 2016: Greatbatch Provides Preliminary 2015 Revenue Results and 2016 Guidance 194

9.3 Legal And Regulatory 194

9.3.1 Dec 02, 2016: Retractable Technologies Reports on Fifth Circuit's Opinion 194

9.3.2 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation 195

9.3.3 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 195

9.3.4 Jun 10, 2016: Insulet Partners with Joslin Diabetes Center to Implement a Unique Training Certification for Insulet's Clinical Team 196

9.3.5 Apr 18, 2016: Henry Ford Breast Cancer Program Granted 3-Year Accreditation 196

9.3.6 Mar 14, 2016: DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement 197

9.3.7 Feb 29, 2016: Baron & Budd Investigating Potential Lawsuits Against Johnson & Johnson Regarding Link Between Talcum Powder and Ovarian Cancer 197

9.4 Other Significant Developments 198

9.4.1 Dec 15, 2016: Lilly Provides 2017 Financial Guidance And 2016 Update, Reaffirms Financial Expectations Through The Remainder Of The Decade 198

9.4.2 Oct 20, 2016: JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D 199

9.4.3 Oct 05, 2016: T1D Exchange Initiates Multi-million Dollar Investment in Automated Insulin Delivery Technologies 200

9.4.4 Sep 06, 2016: Insulet to Establish Highly-Automated Manufacturing Operation in the United States 200

9.4.5 Jul 28, 2016: Tandem Diabetes Care Reports Second Quarter 2016 Financial Results 201

9.4.6 Jun 27, 2016: Greatbatch Renamed Integer Holdings 202

9.5 Strategy And Business Planning 203

9.5.1 Nov 22, 2016: Highly Pathogenic Bird Flu Spreading Across Europe and Asia; BiondVaxs Universal Flu Vaccine Candidate Also Covers these Potential Pandemic Strains 203

9.5.2 Apr 11, 2016: CeQur Initiates Significant Facility Expansion in Marlborough 204

9.5.3 Apr 05, 2016: Allegiance Health Joins Henry Ford Health System 205

9.5.4 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 206

10 Appendix 207

10.1 Research Methodology 208

10.1.1 Coverage 208

10.1.2 Secondary Research 208

10.1.3 Primary Research 209

10.1.4 Company Share Analysis 209

10.1.5 Distribution Share Analysis 209

10.1.6 Benchmarking 210

10.2 GlobalData Consulting 210

10.3 Contact Us 210

10.4 Disclaimer 211

1.2 List of Figures

Figure 1: Insulin Delivery Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022 13

Figure 2: Insulin Delivery Market, North America, Category Comparison by Revenue ($m), USD Constant, 2008-2022 14

Figure 3: Insulin Delivery Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015 15

Figure 4: Insulin Delivery Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022 17

Figure 5: Insulin Delivery Market, North America, Volume (Units), 2008-2022 19

Figure 6: Insulin Delivery Market, North America, Volume (Units), Historic, 2008-2015 21

Figure 7: Insulin Delivery Market, North America, Volume (Units), Forecast, 2015-2022 23

Figure 8: Insulin Delivery Market, North America, Company Share (%) 2015 25

Figure 9: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 27

Figure 10: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 29

Figure 11: Insulin Pens Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 31

Figure 12: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 33

Figure 13: Insulin Pens Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 35

Figure 14: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 37

Figure 15: Insulin Delivery Market, Canada, Volume (Units), Historic, 2008-2015 39

Figure 16: Insulin Delivery Market, Canada, Volume (Units), Forecast, 2015-2022 41

Figure 17: Insulin Pens Market, Canada, Volume (Units), Historic, 2008-2015 43

Figure 18: Insulin Pumps Market, Canada, Volume (Units), Historic, 2008-2015 45

Figure 19: Insulin Pens Market, Canada, Volume (Units), Forecast, 2015-2022 47

Figure 20: Insulin Pumps Market, Canada, Volume (Units), Forecast, 2015-2022 49

Figure 21: Insulin Delivery Market, Canada, Company Share (%) 2015 54

Figure 22: Insulin Delivery Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 56

Figure 23: Insulin Delivery Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 58

Figure 24: Insulin Pens Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 60

Figure 25: Insulin Pumps Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 62

Figure 26: Insulin Pens Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 63

Figure 27: Insulin Pumps Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 65

Figure 28: Insulin Delivery Market, Mexico, Volume (Units), Historic, 2008-2015 66

Figure 29: Insulin Delivery Market, Mexico, Volume (Units), Forecast, 2015-2022 68

Figure 30: Insulin Pens Market, Mexico, Volume (Units), Historic, 2008-2015 70

Figure 31: Insulin Pumps Market, Mexico, Volume (Units), Historic, 2008-2015 72

Figure 32: Insulin Pens Market, Mexico, Volume (Units), Forecast, 2015-2022 73

Figure 33: Insulin Pumps Market, Mexico, Volume (Units), Forecast, 2015-2022 75

Figure 34: Insulin Delivery Market, Mexico, Company Share (%) 2015 79

Figure 35: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 81

Figure 36: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 83

Figure 37: Insulin Pens Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 85

Figure 38: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 87

Figure 39: Insulin Pens Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 89

Figure 40: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 91

Figure 41: Insulin Delivery Market, United States, Volume (Units), Historic, 2008-2015 93

Figure 42: Insulin Delivery Market, United States, Volume (Units), Forecast, 2015-2022 95

Figure 43: Insulin Pens Market, United States, Volume (Units), Historic, 2008-2015 97

Figure 44: Insulin Pumps Market, United States, Volume (Units), Historic, 2008-2015 99

Figure 45: Insulin Pens Market, United States, Volume (Units), Forecast, 2015-2022 101

Figure 46: Insulin Pumps Market, United States, Volume (Units), Forecast, 2015-2022 103

Figure 47: Insulin Delivery Market, United States, Company Share (%) 2015 108

1.1 List of Tables

Table 1: Insulin Delivery Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022 13

Table 2: Insulin Delivery Market, North America, Category Comparison by Revenue ($m), USD Constant, 2008-2022 14

Table 3: Insulin Delivery Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015 16

Table 4: Insulin Delivery Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022 18

Table 5: Insulin Delivery Market, North America, Volume (Units), 2008-2022 20

Table 6: Insulin Delivery Market, North America, Volume (Units), Historic, 2008-2015 22

Table 7: Insulin Delivery Market, North America, Volume (Units), Forecast, 2015-2022 24

Table 8: Insulin Delivery Market, North America, Company Share by Revenue ($m), USD Constant, 2015 26

Table 9: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 28

Table 10: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 30

Table 11: Insulin Pens Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 32

Table 12: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 34

Table 13: Insulin Pens Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 36

Table 14: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 38

Table 15: Insulin Delivery Market, Canada, Volume (Units), Historic, 2008-2015 40

Table 16: Insulin Delivery Market, Canada, Volume (Units), Forecast, 2015-2022 42

Table 17: Insulin Pens Market, Canada, Volume (Units), Historic, 2008-2015 44

Table 18: Insulin Pumps Market, Canada, Volume (Units), Historic, 2008-2015 46

Table 19: Insulin Pens Market, Canada, Volume (Units), Forecast, 2015-2022 48

Table 20: Insulin Pumps Market, Canada, Volume (Units), Forecast, 2015-2022 50

Table 21: Insulin Delivery Market, Canada, Average Price ($) Historic, 2008-2022 51

Table 22: Insulin Delivery Market, Canada, Average Price ($), Forecast, 2015-2022 52

Table 23: Insulin Delivery Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2014-2015 53

Table 24: Insulin Delivery Market, Canada, Company Share by Revenue ($m), USD Constant, 2015 55

Table 25: Insulin Delivery Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 57

Table 26: Insulin Delivery Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 59

Table 27: Insulin Pens Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 61

Table 28: Insulin Pumps Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 62

Table 29: Insulin Pens Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 64

Table 30: Insulin Pumps Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 65

Table 31: Insulin Delivery Market, Mexico, Volume (Units), Historic, 2008-2015 67

Table 32: Insulin Delivery Market, Mexico, Volume (Units), Forecast, 2015-2022 69

Table 33: Insulin Pens Market, Mexico, Volume (Units), Historic, 2008-2015 71

Table 34: Insulin Pumps Market, Mexico, Volume (Units), Historic, 2008-2015 72

Table 35: Insulin Pens Market, Mexico, Volume (Units), Forecast, 2015-2022 74

Table 36: Insulin Pumps Market, Mexico, Volume (Units), Forecast, 2015-2022 75

Table 37: Insulin Delivery Market, Mexico, Average Price ($) Historic, 2008-2022 76

Table 38: Insulin Delivery Market, Mexico, Average Price ($), Forecast, 2015-2022 77

Table 39: Insulin Delivery Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2014-2015 78

Table 40: Insulin Delivery Market, Mexico, Company Share by Revenue ($m), USD Constant, 2015 80

Table 41: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 82

Table 42: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 84

Table 43: Insulin Pens Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 86

Table 44: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 88

Table 45: Insulin Pens Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 90

Table 46: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 92

Table 47: Insulin Delivery Market, United States, Volume (Units), Historic, 2008-2015 94

Table 48: Insulin Delivery Market, United States, Volume (Units), Forecast, 2015-2022 96

Table 49: Insulin Pens Market, United States, Volume (Units), Historic, 2008-2015 98

Table 50: Insulin Pumps Market, United States, Volume (Units), Historic, 2008-2015 100

Table 51: Insulin Pens Market, United States, Volume (Units), Forecast, 2015-2022 102

Table 52: Insulin Pumps Market, United States, Volume (Units), Forecast, 2015-2022 104

Table 53: Insulin Delivery Market, United States, Average Price ($) Historic, 2008-2022 105

Table 54: Insulin Delivery Market, United States, Average Price ($), Forecast, 2015-2022 106

Table 55: Insulin Delivery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 107

Table 56: Insulin Delivery Market, United States, Company Share by Revenue ($m), USD Constant, 2015 109

Table 57: Insulin Delivery Market Pipeline Products 113

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Eli Lilly and Company, Becton Dickinson and Co, Medtronic plc, Novo Nordisk A/S, Sanofi, Insulet Corp, F. Hoffmann-La Roche Ltd, Tandem Diabetes Care, Inc., B. Braun Melsungen AG

Diabetes Care Devices, Glucose Monitoring, Insulin Delivery, Blood Glucose Meters, Lancets, Blood Glucose Test Strips, Insulin Pens, Insulin Syringes, Insulin Pumps, Traditional Insulin Pump Accessories, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic plc, Novo Nordisk A/S, Bayer HealthCare AG, Sanofi, Eli Lilly and Company, Abbott Laboratories, Becton Dickinson and Co, Arkray Inc, Animas Corp, Insulet Corp, Nipro Corp

select a license

Single User License
USD 5995 INR 386558
Site License
USD 11990 INR 773115
Corporate User License
USD 17985 INR 1159673

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com